Czechia· CZ-0272121
VEOZA
A fezolinetant product containing fezolinetant, registered in Czechia by Astellas Pharma Europe B.V., Leiden. The same ATC class is registered in 14 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Fezolinetant is registered in 14 of 19 countries.
Countries holding a registration under ATC G02CX06 (fezolinetant), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 9 of them publish a price we can compare per daily dose
Fezolinetant · ATC G02CX06
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of fezolinetant costs, country by country.
Normalised to the WHO defined daily dose (45 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Fezolinetant · price per daily dose (45 mg)
USD · FX 28 Sept 2026
- ES Spain$3.02
The record
At a glance
SÚKL (Czech Republic)- Active substance
- FEZOLINETANT
- Manufacturer
- Astellas Pharma Europe B.V., Leiden
- Country
- Czechia (CZ)
- ATC code
- G02CX06
- ATC class
- Fezolinetant
- Defined daily dose
- 45 mg, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fezolinetant in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesVEOZAHAstellas Pharma US, Inc.
- SwitzerlandVeoza 45 mg, FilmtablettenAstellas Pharma AG
- FranceVEOZA 45 mg, comprimé pelliculéASTELLAS PHARMA EUROPE (PAYS-BAS)
- BelgiumVeoza 45 mgAstellas Pharma Europe
- IcelandVeozaAstellas Pharma Europe B.V.
- NetherlandsVeoza 45 mg filmomhulde tablettenAstellas Pharma Europe B.V.
- NorwayVeozaAstellas Pharma Europe BV
- PolandVeozaAstellas Pharma Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Veoza
- Liechtenstein · Veoza
- Norway · Veoza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/46669543-a1b5-42f0-83d1-7a2e713b3e6e GET /v1/drugs/46669543-a1b5-42f0-83d1-7a2e713b3e6e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL FLM",
"source": "sukl",
"strength": "45MG",
"pack_size": "28X1",
"substance": "FEZOLINETANT",
"cz_kod_sukl": "0272121",
"product_type": "CH",
"substance_codes": "21146",
"registration_state": "R",
"registration_number": "EU/1/23/1771/001"
}See everything about fezolinetant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.